Item 7.01 Regulation FD.

On April 10, 2023, QSAM Biosciences, Inc. (the "Company") posted an updated corporate presentation on its website, a copy of which is being furnished as Exhibit 99.1 to this report and incorporated herein by reference. The Company may use the presentation, possibly with modifications, in future presentations to current and potential investors, analysts, lenders, business partners, acquisition candidates, customers, employees and others with an interest in the Company and its business.

A copy of the presentation is available on the Company's website at https://ir.qsambio.com/. Materials on the Company's website are not part of or incorporated by reference into this report.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits

The following exhibits are filed with this Current Report on Form 8-K:





Exhibit Number                              Description
     99.1          QSAM Biosciences, Inc. corporate presentation, dated April 10,
                 2023.
     104         Cover Page Interactive Data File (the cover page XBRL tags are
                 embedded within the inline XBRL document).

© Edgar Online, source Glimpses